TG Therapeutics Inc (TGTX) Q2 2019 Earnings Call Transcript [The Motley Fool]
TG Therapeutics, Inc. (TGTX)
Last tg therapeutics, inc. earnings: 11/12 07:34 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.tgtherapeutics.com
Company Research
Source: The Motley Fool
TG Therapeutics Inc (TGTX) Q2 2019 Earnings Call Transcript -- The Motley Fool TG Therapeutics Inc (TGTX) Q 09 Earnings Call Transcript TGTX earnings call for the period ending June 0, 09. MFTranscribers Image source: The Motley Fool. NASDAQ:TGTX Aug 9, 09 8:0 a.m. ET Contents: : Operator Greetings, and welcome to TG Therapeutics Q 09 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to your host Jenna Bosco, Senior Vice President, Corporate Communications. Please go ahead. Senior Vice President, Corporate Communications at TG Therapeutics Thank you. Good morning, and welcome to our conference call regarding TG Therapeutics Second Quarter 09 financial results and business update. I'm Jenna Bosco, TG's Senior Vice President of Corporate Communications and I welcome you to our conference call today. Following our safe harbor statement, Sean Power, TG's Chief Financial Officer, will provide a brief overview of our financial results and then
Show less
Read more
Impact Snapshot
Event Time:
TGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TGTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TGTX alerts
High impacting TG Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TGTX
News
- TG Therapeutics jumps 56% amid FDA labeling talks for multiple sclerosis therapy [Seeking Alpha]Seeking Alpha
- TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial ResultsGlobeNewswire
- TG Therapeutics to Host Conference Call on Third Quarter 2022 Financial Results and Business UpdateGlobeNewswire
- TG Therapeutics Announces Presentation of Exploratory Analyses from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis Presented at the 2022 European Committee for Treatment and Research in Multiple SclerosisGlobeNewswire
- TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at the 2022 European Committee for Treatment and Research in Multiple SclerosisGlobeNewswire
TGTX
Earnings
- 11/9/22 - Beat
TGTX
Sec Filings
- 11/10/22 - Form 8-K
- 11/9/22 - Form 10-Q
- 10/11/22 - Form SC
- TGTX's page on the SEC website